Medical devices, healthcare technology and the business of care
510(k) clearance · K262983

EsTemp Implant

Spident Co., Ltd. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONK262983

What did the FDA decide?

FDA recorded a substantial equivalence determination for K262983, EsTemp Implant, on September 25, 2026, with the submission received August 27, 2026. The applicant is Spident Co., Ltd. of Incheon, Republic of Korea. The device falls under 21 CFR 872.3275 (Dental Cement), Class II, product code EMA, in the Dental specialty. The letter states the device is substantially equivalent to legally marketed predicate devices for the indications for use stated in the enclosure; that enclosure is not reproduced in the available source text.

This is a 510(k) clearance, not a premarket approval. The letter permits marketing subject to general controls and notes registration, listing, labeling, medical device reporting and Quality Management System Regulation obligations, and that changes significantly affecting safety or effectiveness require a new premarket notification under 21 CFR 807.81. The source does not include the indications for use, predicate device identities, or any performance or clinical data, so the basis for the equivalence finding cannot be assessed here.

The available material does not describe the device's composition, design, or intended clinical use beyond its regulation and product code, and no clinical or efficacy conclusions are drawn.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Sep 25, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262983
Regulatory pathway
510(k) premarket notification
Product code
EMA
Decision code
SESE
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cement, Dental.

Product code
EMA
FDA device class
2

FDA decision timeline

  1. K262983 received

    Application receipt date recorded by FDA.

  2. K262983 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Spident Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Incheon

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records